You are here

Share

Article menu

Download PDFPDF

Thursday 06 October 2022 from 13:00 to 14:10
PO.4 E- POSTER SESSION 4: disease activity measurements, flare and remission, epidemiology, etiology, genetics, epigenetics
PO.4.75 The anti-BDCA2 antibody biib059 improves joint and skin manifestations in patients with SLE and both active arthritis and rash

Share this article

Click the icon of the social media platform on which you would like to share this article.

del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo LinkedIn logo Mendeley logo

Email this article to a friend

We will not keep your email address; we ask for it so your friend knows the email isn't spam.
Enter multiple addresses on separate lines or separate them with commas.
PO.4.75 The anti-BDCA2 antibody biib059 improves joint and skin manifestations in patients with SLE and both active arthritis and rash
(Your Name) has forwarded a page to you from Lupus Science & Medicine
(Your Name) thought you would like to see this page from the Lupus Science & Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.